Aquestive Therapeutics, Inc. (AQST) — Stock Score Summary

Aquestive Therapeutics, Inc. (AQST) has a MoatMap StockRank of 16/100 based on Quality (30/100), Value (47/100), and Momentum (24/100) factor scores. The current signal is STRONG SELL. A US healthcare (biotech) company. Similar to other biotechs, it lacks direct macro tailwinds, clear quality compounder attributes, and involves high R&D risk. The 'STRONG_SELL' signal is a strong deterrent.

Aquestive Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing film-based drug delivery products, primarily for unmet medical needs in central nervous system (CNS) disorders. Its proprietary PharmFilm® technology enables convenient, rapid-onset, and non-invasive administration of medications. This specialized drug delivery platform provides a distinct advantage in developing differentiated therapeutic options.

Key Financial Metrics

Price$4.02
Market Cap$504M
P/E (Forward)-9.07
Price/Book-14.89
Return on Invested Capital-59.1%
Gross Margin63.5%
Operating Margin-29.1%
Revenue Growth65.7%
Free Cash Flow$-26M

Aquestive Therapeutics, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Aquestive Therapeutics, Inc.’s (AQST) StockRank?
MoatMap’s StockRank for Aquestive Therapeutics, Inc. (AQST) is 16/100, with a Strong Sell signal. It is a composite of Quality (30), Value (47), and Momentum (24) factor ranks across MoatMap’s 19,000+ stock universe.
Does Aquestive Therapeutics, Inc. have an economic moat?
Aquestive Therapeutics, Inc. (AQST) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Aquestive Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Aquestive Therapeutics, Inc. (AQST) is Strong Sell, based on a StockRank of 16/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Aquestive Therapeutics, Inc. in?
Aquestive Therapeutics, Inc. (AQST) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksAQST deep dive reportAI ChampionsHow we score stocksSense-check another stock